astro med - ALOT

ALOT

Close Chg Chg %
9.28 0.22 2.37%

Closed Market

9.50

+0.22 (2.37%)

Volume: 37.63K

Last Updated:

Feb 6, 2026, 4:00 PM EDT

Company Overview: astro med - ALOT

ALOT Key Data

Open

$9.43

Day Range

9.43 - 10.00

52 Week Range

6.96 - 12.68

Market Cap

$68.44M

Shares Outstanding

7.64M

Public Float

6.03M

Beta

0.73

Rev. Per Employee

N/A

P/E Ratio

N/A

EPS

-$2.23

Yield

0.00%

Dividend

$0.07

EX-DIVIDEND DATE

Mar 25, 2020

SHORT INTEREST

N/A

AVERAGE VOLUME

14.61K

 

ALOT Performance

1 Week
 
4.51%
 
1 Month
 
3.04%
 
3 Months
 
7.22%
 
1 Year
 
-19.49%
 
5 Years
 
-13.83%
 

ALOT Analyst Ratings

  • Sell
  • Under
  • Hold
  • Over
  • Buy
Number of Ratings 1
Full Ratings ➔

About astro med - ALOT

AstroNova, Inc. engages in the design, development, manufacture, and distribution of printers and data acquisition and analysis systems. It operates through the Product Identification (PI) and Test and Measurement (T&M) segments. The PI segment includes digital label printers, over-printers, labeling software, spare parts, service contracts, and related printing supplies such as pressure sensitive labels, tags, inks, toners, and thermal transfer ribbons used in product identification digital printers. The T&M segment offers a line of aerospace printers that are used to print hard copies of data required for the operation of aircraft including navigation maps, arrival and departure procedures, flight itineraries, weather maps, performance data, passenger data, and various air traffic control data. The company was founded by Albert W. Ondis on January 9, 1969 and is headquartered in West Warwick, RI.

ALOT At a Glance

AstroNova, Inc.
600 East Greenwich Avenue
West Warwick, Rhode Island 02893
Phone 1-401-828-4000 Revenue 151.28M
Industry Computer Peripherals Net Income -14,489,000.00
Sector Electronic Technology 2025 Sales Growth 2.159%
Fiscal Year-end 01 / 2026 Employees 441
View SEC Filings

ALOT Valuation

P/E Current N/A
P/E Ratio (with extraordinary items) N/A
P/E Ratio (without extraordinary items) N/A
Price to Sales Ratio 0.576
Price to Book Ratio 1.155
Price to Cash Flow Ratio 17.97
Enterprise Value to EBITDA 13.247
Enterprise Value to Sales 0.879
Total Debt to Enterprise Value 0.383

ALOT Efficiency

Revenue/Employee 343,045.351
Income Per Employee -32,854.875
Receivables Turnover 7.13
Total Asset Turnover 1.085

ALOT Liquidity

Current Ratio 1.681
Quick Ratio 0.648
Cash Ratio 0.109

ALOT Profitability

Gross Margin 34.736
Operating Margin 3.479
Pretax Margin -8.122
Net Margin -9.577
Return on Assets -10.392
Return on Equity -17.453
Return on Total Capital -11.433
Return on Invested Capital -14.469

ALOT Capital Structure

Total Debt to Total Equity 67.304
Total Debt to Total Capital 40.229
Total Debt to Total Assets 35.017
Long-Term Debt to Equity 28.627
Long-Term Debt to Total Capital 17.111
  • Income Statement
  • Balance Sheet
  • Cash Flow Statement

Annual Financials for Astro Med - ALOT

Collapse All in section
All values USD millions. 2022 2023 2024 2025 5-year trend
Sales/Revenue
117.48M 142.53M 148.09M 151.28M
Sales Growth
+1.25% +21.32% +3.90% +2.16%
Cost of Goods Sold (COGS) incl D&A
73.74M 94.37M 94.40M 98.73M
COGS excluding D&A
- - - -
-
Depreciation & Amortization Expense
3.99M 3.92M 4.27M 4.78M
Depreciation
1.79M 2.02M 1.87M 2.10M
Amortization of Intangibles
2.20M 1.90M 2.40M 2.68M
COGS Growth
-1.25% +27.98% +0.03% +4.59%
Gross Income
43.74M 48.16M 53.69M 52.55M
Gross Income Growth
+5.75% +10.10% +11.48% -2.12%
Gross Profit Margin
+37.23% +33.79% +36.25% +34.74%
2022 2023 2024 2025 5-year trend
SG&A Expense
39.48M 42.01M 41.61M 47.29M
Research & Development
6.75M 6.82M 6.88M 6.61M
Other SG&A
32.73M 35.19M 34.74M 40.68M
SGA Growth
+1.43% +6.41% -0.95% +13.63%
Other Operating Expense
- - - -
-
Unusual Expense
(4.47M) 700.00K 3.28M 14.60M
EBIT after Unusual Expense
8.72M 5.44M 8.80M (9.34M)
Non Operating Income/Expense
(1.01M) (355.00K) (26.00K) 263.00K
Non-Operating Interest Income
- - - -
-
Equity in Earnings of Affiliates
- - - -
-
Interest Expense
677.00K 1.68M 2.70M 3.21M
Interest Expense Growth
-29.11% +147.86% +60.73% +19.02%
Gross Interest Expense
677.00K 1.68M 2.70M 3.21M
Interest Capitalized
- - - -
-
Pretax Income
7.03M 3.41M 6.07M (12.29M)
Pretax Income Growth
+222.81% -51.52% +78.09% -302.32%
Pretax Margin
+5.99% +2.39% +4.10% -8.12%
Income Tax
605.00K 749.00K 1.38M 2.20M
Income Tax - Current - Domestic
(107.00K) 1.22M 1.04M 1.26M
Income Tax - Current - Foreign
501.00K 870.00K 420.00K 153.00K
Income Tax - Deferred - Domestic
357.00K (1.37M) (30.00K) (634.00K)
Income Tax - Deferred - Foreign
(146.00K) 32.00K (48.00K) 1.42M
Income Tax Credits
- - - -
-
Equity in Earnings of Affiliates
- - - -
-
Other After Tax Income (Expense)
- - - -
-
Consolidated Net Income
6.43M 2.66M 4.69M (14.49M)
Minority Interest Expense
- - - -
-
Net Income
6.43M 2.66M 4.69M (14.49M)
Net Income Growth
+400.70% -58.61% +76.40% -408.67%
Net Margin Growth
+5.47% +1.87% +3.17% -9.58%
Extraordinaries & Discontinued Operations
- - - -
-
Discontinued Operations
- - - -
-
Net Income After Extraordinaries
6.43M 2.66M 4.69M (14.49M)
Preferred Dividends
- - - -
-
Net Income Available to Common
6.43M 2.66M 4.69M (14.49M)
EPS (Basic)
0.892 0.3642 0.633 -1.9296
EPS (Basic) Growth
+393.64% -59.17% +73.81% -404.83%
Basic Shares Outstanding
7.21M 7.31M 7.42M 7.51M
EPS (Diluted)
0.876 0.3609 0.6262 -1.9296
EPS (Diluted) Growth
+388.84% -58.80% +73.51% -408.14%
Diluted Shares Outstanding
7.34M 7.37M 7.50M 7.51M
EBITDA
8.25M 10.06M 16.34M 10.04M
EBITDA Growth
-1.97% +21.93% +62.42% -38.53%
EBITDA Margin
+7.02% +7.06% +11.03% +6.64%

Insider Actions for Astro Med - ALOT

Date Name Shares Transaction Value
Apr 2, 2025 Darius G. Nevin Director 765 Grant, award or other acq pursuant to Rule 16b-3(d) 0.00

Astro Med in the News